{
    "abstract": "This study aimed to determine the rate of salvage chemotherapy and review associated factors in invasive mole patients treated by primary or delayed hysterectomy.\nThis study was carried out at the Tu Du Hospital, where a total of 189 patients were diagnosed with invasive mole based on histologic examination by hysterectomy between 01/2016 to 12/2020. We used the life table method to estimate the cumulative rate. We applied the Cox proportional hazard model to determine the factors associated with the need for salvage chemotherapy.\nAt 12-month follow-up, 47 patients had required salvage chemotherapy. The incidence was 24.87% (95% CI: 18.88-31.66). Applying the multivariate model, prophylactic chemotherapy (HR = 2.75, 95% Cl: 1.20-6.30) and two weeks postoperative hCG value greater than 1,900 mIU/mL (HR = 4.30, 95% Cl: 2.08-8.87) increased the risk of requiring salvage chemotherapy. Postoperative chemotherapy decreased the risk of requiring salvage chemotherapy (HR = 0.43, 95% Cl: 0.22-0.83).\nHysterectomy can be considered safe and effective in treating invasive mole patients. Although patients were treated by hysterectomy, 24.87% of patients needed salvage chemotherapy to achieve remission. This study affirms the malignant nature of invasive mole, a subtype of gestational trophoblastic neoplasia (GTN). It is not purely a local invasion of molar villi. Postoperative chemotherapy plays an essential role in reducing the risk of requiring salvage chemotherapy.",
    "authors": [
        {
            "affiliation": "University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam. vominhtuan@ump.edu.vn.",
            "firstname": "T",
            "initials": "T",
            "lastname": "Vo"
        },
        {
            "affiliation": null,
            "firstname": "T",
            "initials": "T",
            "lastname": "Tran"
        },
        {
            "affiliation": null,
            "firstname": "T",
            "initials": "T",
            "lastname": "Ho"
        },
        {
            "affiliation": null,
            "firstname": "C",
            "initials": "C",
            "lastname": "Le"
        },
        {
            "affiliation": null,
            "firstname": "H",
            "initials": "H",
            "lastname": "Pham"
        },
        {
            "affiliation": null,
            "firstname": "H",
            "initials": "H",
            "lastname": "Tran"
        },
        {
            "affiliation": null,
            "firstname": "N",
            "initials": "N",
            "lastname": "Ho"
        },
        {
            "affiliation": null,
            "firstname": "T",
            "initials": "T",
            "lastname": "Cao"
        },
        {
            "affiliation": null,
            "firstname": "B",
            "initials": "B",
            "lastname": "Vo"
        }
    ],
    "conclusions": null,
    "copyrights": null,
    "doi": "10.26355/eurrev_202308_33426",
    "journal": "European review for medical and pharmacological sciences",
    "keywords": [],
    "methods": null,
    "publication_date": "2023-09-05",
    "pubmed_id": "37667950",
    "results": "At 12-month follow-up, 47 patients had required salvage chemotherapy. The incidence was 24.87% (95% CI: 18.88-31.66). Applying the multivariate model, prophylactic chemotherapy (HR = 2.75, 95% Cl: 1.20-6.30) and two weeks postoperative hCG value greater than 1,900 mIU/mL (HR = 4.30, 95% Cl: 2.08-8.87) increased the risk of requiring salvage chemotherapy. Postoperative chemotherapy decreased the risk of requiring salvage chemotherapy (HR = 0.43, 95% Cl: 0.22-0.83).",
    "title": "Clinical evaluation of hysterectomy for the treatment of invasive mole in Southern Vietnam.",
    "xml": "<Element 'PubmedArticle' at 0x788506c651c0>"
}